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Background: Angiogenic squamous dysplasia (ASD) is a dysplastic 
lesion of the bronchial airways that is distinguished from other dys-
plasias by virtue of the presence of characteristic vascular morphology 
with projection of microvessels into the overlying dysplastic epithe-
lium. These lesions are associated with increased VEGF expression and 
high microvessel densities (MVD) in comparison to normal bronchial 
epithelium. In addition, we have recently demonstrated these lesions to 
be associated with longer periods of persistence in comparison to non-
ASD bronchial dysplasia. 
Methods: Immunohistochemical stains for CD31 and actin were 
performed on consecutive sections of bronchoscopically obtained 
biopsy material. CD31 and actin vessel densities for identical areas 
within each biopsy were produced by image analysis with collection 
of area measurements and vessel tags. A microvessel maturation index 
(MMI) was calculated via division of actin MVDs by CD31 MVDS 
for each biopsy. In addition, single vessel analyses were performed for 
microvessel papillary structures in ASD lesions.
Results: The mean MMI for twelve dysplastic lesions was signiﬁcantly 
less than that measured for four normal bronchial biopsies (MMI 0.62 
vs. 1.02, respectively; p=0.04). When analyzed independently, the 
vessels that project into the intraepithelial papillae of ASDs showed the 
lowest MMI of 0.56. This was not statistically different than the MMI 
for the dysplasia group as a whole but was signiﬁcantly decreased in 
comparison to normal MMI (p=0.71 and 0.04, respectively). Incom-
plete vascular maturation appears to be associated with dysplastic 
change in the bronchial airways and is most striking in the vascular 
structures of ASDs.
Conclusions: Angiogenesis in bronchial dysplasia is associated with 
reduced vascular maturation. Immature vasculature may have an 
impact on the growth and progression of dysplastic lesions. Increased 
delivery of pro-tumorigenic factors such as growth promoting factors 
and mutagenic substances may be facilitated by immature vascular net-
works. Further analysis of ASD associated vasculature may allow for 
the identiﬁcation of angiogenic mediators that control the maturation of 
microvessels in pre-neoplastic airway disease.
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Background: Alterations in genome structure (e.g. ampliﬁcations and 
deletions) have been identiﬁed as features of many types of cancer 
including lung cancer. A major challenge in the molecular study of lung 
cancer is the limited quantity of tumour tissue available from routine 
biopsy procedures. To address this challenge, whole genome ampliﬁca-
tion (WGA) methods utilizing Phi29 polymerase were developed to 
increase the amount of DNA available for analysis. The high sequence 
ﬁdelity of these techniques has been investigated using low resolution 
assays however the use of ampliﬁed material for copy number analysis 
has been questioned due to ampliﬁcation-induced bias. In this study, we 
investigate the use of ampliﬁed material for genome-wide copy number 
analysis of limited quantities of patient material.
Methods: Normal lymph nodes from three patients were fresh-frozen 
in OCT compound for tissue archival. DNA from these sources was 
extracted and 7ng (~1000 cell equivalents) subject to WGA using the 
QIAgen Repli-G Mini kit to generate over 10,000ng of product (~1.4M 
cell equivalents). To identify artifacts induced by the ampliﬁcation 
technique, pre- and post- ampliﬁcation samples were hybridized to the 
Affymetrix GeneChip Mapping 500k SNP and NimbleGen 384k CGH 
array platforms. Pre- and post- ampliﬁcation copy number comparisons 
were conducted to identify ampliﬁcation-induced copy number  
differences.
Results: Preliminary copy number analysis of the Affymetrix data from 
pre- and post-ampliﬁcation sample pairs has identiﬁed more than 700 
sites which were commonly over- or under-ampliﬁed. 63 of these sites, 
representing a maximum of 59Mb and often in telomeric regions, were 
under-ampliﬁed. 683 sites, representing a maximum of 685Mb and 
primarily in GC-rich regions, were commonly over-ampliﬁed.
Compensation for these reproducible biases can be achieved by com-
paring ampliﬁed samples to ampliﬁed samples. Preliminary pair-wise 
comparisons of ampliﬁed samples have shown recapitulation of copy 
number differences detected in corresponding unampliﬁed com-
parisons. In the example shown in Figure 1, the unampliﬁed (a) and 
ampliﬁed copy number comparison (c) identiﬁed 14 and 89 variants 
respectively. Both comparisons identiﬁed the relative increase in copy 
number marked by the arrow as the most signiﬁcant (p<0.0001).
Figure 1: Example of copy number detection using unamplified and amplified 
pair-wise comparisons
